Hexylcaine
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. (December 2009) |
| Systematic (IUPAC) name | |
|---|---|
| 1-cyclohexylaminopropan-2-yl benzoate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Half-life | <10 minutes |
| Identifiers | |
| CAS number | 532-77-4 |
| ATC code | None |
| PubChem | CID 10770 |
| DrugBank | DB00473 |
| ChemSpider | 10315 |
| UNII | 511IU0826Z |
| KEGG | C14172 |
| ChEMBL | CHEMBL1197 |
| Chemical data | |
| Formula | C16H23NO2 |
| Mol. mass | 261.359 g/mol |
|
|
|
|
| |
|
Hexylcaine hydrochloride, also called cyclaine (Merck) or osmocaine, is a short-acting local anesthetic. It acts by inhibiting sodium channel conduction. Overdose can lead to headache, tinnitus, numbness and tingling around the mouth and tongue, convulsions, inability to breathe, and decreased heart function.
|
|||||||||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |